KNB logo

Kanabo Group Plc Stock Price

LSE:KNB Community·UK£1.4m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

KNB Share Price Performance

UK£0.0022
-0.01 (-75.00%)
UK£0.0022
-0.01 (-75.00%)
Price UK£0.0022

KNB Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet slight.

4 Risks
1 Reward

Kanabo Group Plc Key Details

UK£1.1m

Revenue

UK£1.1m

Cost of Revenue

UK£90.0k

Gross Profit

UK£8.3m

Other Expenses

-UK£8.2m

Earnings

Last Reported Earnings
Jun 30, 2024
Next Reporting Earnings
n/a
-0.013
7.89%
-717.63%
3.5%
View Full Analysis

About KNB

Founded
2016
Employees
20
CEO
Avihu Tamir
WebsiteView website
www.kanabogroup.com

Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain. It also provides cultivation consultancy for cannabis businesses, as well as develops and distributes cannabis derived medicinal and wellness products. Kanabo Group Plc was incorporated in 2016 and is based in London, the United Kingdom.

Recent KNB News & Updates

Recent updates

No updates